Luippold G, Schneider S, Stefanescu A, Benöhr P, Mühlbauer B
Department of Pharmacology, University of Tübingen, Centre of Clinical Pharmacology Tübingen-Stuttgart, D-72074 Tübingen, Germany.
Br J Clin Pharmacol. 2001 May;51(5):415-21. doi: 10.1046/j.1365-2125.2001.01373.x.
In rodents, blockade of dopamine D2-like receptors abolishes both the physiological increase in glomerular filtration rate (GFR) induced by amino acids and the pathological hyperfiltration in experimental diabetes mellitus. This study addressed the contribution of dopamine D2-like receptors to changes in renal haemodynamics after amino acid infusion in humans.
Twelve healthy volunteers participated in this double-blind, randomized, cross-over study. GFR and renal blood flow (RPF) were assessed by renal clearance of inulin and p-aminohippuric acid (PAH), respectively. Following infusion of 0.45% saline at baseline, an electrolyte-balanced solution of mixed amino acids (10%) was infused. Prior to the experiments, the subjects received orally either placebo, or sulpiride (10 mg kg-1), a centrally and peripherally acting D2-like receptor antagonist, or domperidone (1 mg kg-1) which affects only peripheral D2-like receptors.
In the placebo series, amino acid infusion significantly increased GFR and RPF by up to 15.8 +/- 5.3% and 14.4 +/- 6.1%, respectively, while mean blood pressure and heart rate remained unchanged. Pretreatment with domperidone only marginally altered the renal response to amino acids (maximal increase by 13.2 +/- 5.6 and 11.9 +/- 4.0% in GFR and RPF, respectively), while sulpiride completely abolished the renal haemodynamic changes induced by amino acids. Total and fractional urinary sodium excretion as well as urinary osmolality were similar at baseline and increased in response to amino acids, to the same extent, in all series. No changes in renal dopamine excretion occurred.
The results indicate that in man dopamine D2-like receptors are involved in the renal haemodynamic response to amino acid infusion. Whether dopamine D2-like receptor blockade diminishes glomerular hyperfiltration in pathological states requires clinical investigations.
在啮齿动物中,阻断多巴胺D2样受体可消除由氨基酸诱导的肾小球滤过率(GFR)的生理性增加以及实验性糖尿病中的病理性超滤。本研究探讨了多巴胺D2样受体在人类输注氨基酸后肾血流动力学变化中的作用。
12名健康志愿者参与了这项双盲、随机、交叉研究。分别通过菊粉和对氨基马尿酸(PAH)的肾清除率评估GFR和肾血流量(RPF)。在基线时输注0.45%盐水后,输注混合氨基酸(10%)的电解质平衡溶液。在实验前,受试者口服安慰剂、舒必利(10 mg kg-1)(一种中枢和外周作用的D2样受体拮抗剂)或多潘立酮(1 mg kg-1)(仅影响外周D2样受体)。
在安慰剂组中,输注氨基酸使GFR和RPF分别显著增加高达15.8±5.3%和14.4±6.1%,而平均血压和心率保持不变。多潘立酮预处理仅轻微改变了肾脏对氨基酸的反应(GFR和RPF分别最大增加13.2±5.6%和11.9±4.0%),而舒必利完全消除了氨基酸诱导的肾血流动力学变化。所有组中,总尿钠排泄量和尿钠排泄分数以及尿渗透压在基线时相似,并且对氨基酸的反应在相同程度上增加。肾多巴胺排泄无变化。
结果表明,在人类中,多巴胺D2样受体参与了对输注氨基酸的肾血流动力学反应。多巴胺D2样受体阻断是否能减轻病理状态下的肾小球超滤需要临床研究。